Galectin Therapeutics
GALT
GALT
65 hedge funds and large institutions have $58.6M invested in Galectin Therapeutics in 2014 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
45% less call options, than puts
Call options by funds: $1.92M | Put options by funds: $3.46M
Holders
65
Holding in Top 10
–
Calls
$1.92M
Puts
$3.46M
Top Buyers
| 1 | +$6.24M | |
| 2 | +$5.42M | |
| 3 | +$2.7M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.35M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$914K |
Top Sellers
| 1 | -$3.06M | |
| 2 | -$2.76M | |
| 3 | -$2.48M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.04M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.97M |